Wuhan Hiteck Biological Pharma Co.,Ltd (300683.SZ)
CNY 25.59
(0.35%)
CNY 25.59
(0.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 5.31 Million | 53.03 Million | 12.08 Million | -19.7 Million | 63.02 Million | 73.42 Million |
| Net Income | -128.24 Million | -7.89 Million | 30.01 Million | -25.67 Million | 61.18 Million | 91.46 Million |
| Depreciation & Amortization | 71.07 Million | 53.47 Million | 37.9 Million | 28.99 Million | 23.2 Million | 13.73 Million |
| Deferred income taxes | -25.51 Million | -3.09 Million | -14.7 Million | -23.63 Million | -7.43 Million | -7.54 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 12.2 Million | -7.87 Million | -56.77 Million | -64.62 Million | -13.75 Million | -50.34 Million |
| Other non-cash items | 50.28 Million | 15.33 Million | 942.87 Thousand | 41.6 Million | -7.61 Million | 18.56 Million |
| Investing Cash Flow | -491.92 Million | 525.35 Million | -953 Million | -196.13 Million | 342.95 Million | -438.73 Million |
| Investments in PPE | -167.44 Million | -173.97 Million | -247.11 Million | -113.62 Million | -116.15 Million | -38.66 Million |
| Acquisitions | 2.06 Million | -19.72 Million | -192.71 Million | -22.14 Million | -35.49 Million | -242.08 Million |
| Investment purchases | -1.8 Billion | -1.12 Billion | -2 Billion | -1.01 Billion | -1.41 Billion | -227.05 Million |
| Sales/Maturities of investments | 1.48 Billion | 1.84 Billion | 1.49 Billion | 957.22 Million | 1.91 Billion | 69.06 Million |
| Other Investing Activities | -125.99 Thousand | -166.62 Thousand | -178.82 Thousand | 35.92 Thousand | 599.96 | 2000.56 |
| Financing Cash Flow | 248.29 Million | -12.28 Million | 662.81 Million | -8.18 Million | -28.48 Million | -25.19 Million |
| Debt repayment | -37.25 Million | -8.05 Million | -76.63 Million | -39 Million | -7.8 Million | - |
| Dividends payments | -2.2 Million | -1.33 Million | -62 Thousand | -16.53 Million | -20.67 Million | -31.16 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -417.45 Thousand | -200 Thousand | -2 Million | - | - | - |
| Other Financing Activities | 287.74 Million | -2.89 Million | 586.24 Million | 47.8 Million | -9505.28 | 5.96 Million |
| Accounts receivables | 24.42 Million | 13.48 Million | -67.49 Million | -16.4 Million | 22.51 Million | 28.25 Million |
| Accounts payables | 35.19 Million | 34.17 Million | 26.17 Million | -22.77 Million | -3.93 Million | -58.99 Million |
| Inventory | -21.9 Million | -52.45 Million | -750.73 Thousand | -1.8 Million | -24.89 Million | -12.05 Million |
| Other working capital | 34.1 Million | -3.09 Million | -14.7 Million | -23.63 Million | -7.43 Million | -38.28 Million |
| Cash at beginning of period | 748.47 Million | 182.32 Million | 460.47 Million | 684.57 Million | 307.07 Million | 697.58 Million |
| Cash at end of period | 510.16 Million | 748.47 Million | 182.32 Million | 460.47 Million | 684.57 Million | 307.07 Million |
| Capital Expenditure | -167.44 Million | -173.97 Million | -247.11 Million | -113.62 Million | -116.15 Million | -38.66 Million |
| Effect of forex changes on cash | 12.95 Thousand | 49.77 Thousand | -41.07 Thousand | -75.66 Thousand | -0.25 | 0.40 |
| Net cash flow / Change in cash | -238.31 Million | 566.15 Million | -278.14 Million | -224.09 Million | 377.5 Million | -390.51 Million |
| Free Cash Flow | -162.12 Million | -120.93 Million | -235.02 Million | -133.33 Million | -53.12 Million | 34.75 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.97 Million | -6.22 Million | -16.54 Million | -94.38 Million | -128.24 Million | -15.31 Million |
| Depreciation & Amortization | - | 23.2 Million | 23.2 Million | 17.79 Million | 71.07 Million | -36.87 Million |
| Deferred income taxes | - | - | - | - | -25.51 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -34.85 Million | - | 2.51 Million | 12.2 Million | 37.55 Million |
| Other non-cash items | 21.83 Million | 56.64 Million | 26.16 Million | 170.96 Million | 50.28 Million | 5.34 Million |
| Investing Cash Flow | 119.45 Million | -102.05 Million | -51.26 Million | -7.04 Million | -491.92 Million | 93.27 Million |
| Investments in PPE | -5.51 Million | -7.07 Million | -16.86 Million | -69.79 Million | -167.44 Million | -41.25 Million |
| Acquisitions | 15 Thousand | - | - | 0.58 | 2.06 Million | 1.8 Million |
| Investment purchases | -330.7 Million | -511.21 Million | -207.81 Million | -334.68 Million | -1.8 Billion | -44.58 Million |
| Sales/Maturities of investments | 455.65 Million | 416.23 Million | 173.41 Million | 390.46 Million | 1.48 Billion | 177.3 Million |
| Other Investing Activities | 15 Thousand | -88.85 Million | 0.75 | 6.96 Million | -125.99 Thousand | -0.16 |
| Financing Cash Flow | -5.87 Million | -4.48 Million | -4.79 Million | -14.64 Million | 248.29 Million | 8.8 Million |
| Debt repayment | -3.65 Million | -3.65 Million | -3.65 Million | -13.65 Million | -37.25 Million | -1.2 Million |
| Dividends payments | -419.17 Thousand | -466.25 Thousand | -507.94 Thousand | -1.61 Million | -2.2 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | -417.45 Thousand | -417.45 Thousand | - |
| Other Financing Activities | -1.8 Million | 173.92 Thousand | -640.18 Thousand | 619.7 Thousand | 287.74 Million | 10 Million |
| Accounts receivables | - | -30.05 Million | - | 24.42 Million | 24.42 Million | 14.13 Million |
| Accounts payables | - | - | - | - | 35.19 Million | - |
| Inventory | - | -4.79 Million | - | -21.9 Million | -21.9 Million | 23.42 Million |
| Other working capital | - | - | - | - | 34.1 Million | - |
| Cash at beginning of period | 383.92 Million | 463.29 Million | 510.16 Million | 482.79 Million | 748.47 Million | 393.34 Million |
| Cash at end of period | 495 Million | 383.92 Million | 463.24 Million | 510.16 Million | 510.16 Million | 482.79 Million |
| Capital Expenditure | -5.51 Million | -7.07 Million | -16.86 Million | -69.79 Million | -167.44 Million | -41.25 Million |
| Effect of forex changes on cash | -719.24 | 658.08 | 53.29 | -26.95 Thousand | 12.95 Thousand | -0.07 |
| Net cash flow / Change in cash | 111.08 Million | -79.36 Million | -46.92 Million | 27.37 Million | -238.31 Million | 89.44 Million |
| Free Cash Flow | -662.62 Thousand | 20.14 Million | -7.72 Million | -20.69 Million | -162.12 Million | -50.53 Million |
QIIWI
STAR-B
002390
LRDSF
PODP
SNRG